Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK.
J Glaucoma. 2022 Apr 1;31(4):268-273. doi: 10.1097/IJG.0000000000001994.
Irrigating goniectomy with the TrabEx+ device can lower intraocular pressure (IOP) in patients with glaucoma, as a standalone procedure or combined with cataract surgery.
The aim was to describe the efficacy and safety of irrigating goniectomy performed using the TrabEx+ device, either as a standalone procedure or combined with cataract surgery, in eyes with medically treated open-angle glaucoma.
A retrospective case series of eyes treated by a single surgeon at a single UK teaching hospital. Data was collected at follow-up visits at 1 week, 3, 6, 12, 18, and 24 months postoperatively. Primary outcomes included IOP and glaucoma medication reduction after surgery. Proportion of eyes achieving >20% IOP reduction, IOP <21 mm Hg, and no reoperation were classified as surgical success.
Seventy-three consecutive eyes of 64 patients (mean age 68.4±13.7 y) were enrolled. 62% were treated as combined procedures with cataract surgery. Overall, mean IOP decreased from 31.3±7.3 to 20.9±10.4 mm Hg at the latest follow-up (34% reduction) (P<0.001) at the latest follow-up (16.1±10.3 mo) with mean preoperative medications decreased from 2.9±1.2 to 1.9±1.3 (P<0.001). 73% met the definition of success at latest follow-up. Postoperative complications were recorded including hyphaema (17%), uveitis (3%), hypotony (1%), and persistent vitreous hemorrhage (1%). Eighteen percent required reoperation because of treatment failure.
TrabEx+ appears to be effective in lowering IOP and medication with or without cataract surgery. However, long-term safety and efficacy will be better understood in a prospective study with longer follow-up.
使用 TrabEx+ 设备进行小梁切开冲洗术可降低青光眼患者的眼内压(IOP),可作为单一程序或与白内障手术联合进行。
描述使用 TrabEx+ 设备进行小梁切开冲洗术的疗效和安全性,该手术可作为单一程序或与白内障手术联合用于接受药物治疗的开角型青光眼患者。
回顾性病例系列,由英国一家教学医院的一位外科医生对患者进行治疗。数据在术后 1 周、3、6、12、18 和 24 个月的随访中收集。主要结局包括术后眼压和青光眼药物的降低。将术后眼压降低超过 20%、眼压<21mmHg 且无需再次手术的眼比例归类为手术成功。
纳入 64 例患者的 73 只连续眼(平均年龄 68.4±13.7 岁)。62%作为白内障手术联合治疗。总体而言,平均眼压从 31.3±7.3mmHg 降至 20.9±10.4mmHg(34%的降幅)(P<0.001),最新随访时(16.1±10.3 个月)平均术前药物用量从 2.9±1.2 降至 1.9±1.3(P<0.001)。最新随访时 73%的患者符合成功定义。术后并发症包括前房积血(17%)、虹膜炎(3%)、低眼压(1%)和持续性玻璃体积血(1%)。18%的患者因治疗失败需要再次手术。
TrabEx+似乎可有效降低眼压和药物治疗,无论是否行白内障手术。然而,在一项具有更长随访时间的前瞻性研究中,将更好地了解其长期安全性和疗效。